Dr Reddy's shares up 5% on US FDA OK

Shares in drug maker Dr Reddy's Laboratories rose over 5 percent early in the day on a likely US FDA approval for its drug, two dealers said.

At 10.41 a.m. shares were at 1,594 rupees, up 3.29 percent, but off its high of 1,622.95 rupees, out of breath after the company said it has received U.S. FDA approval for its fondaparinux sodium injection and will also manufacture fondaparinux under license using a patented process developed by Alchemia Ltd.

Company INFO

More on Dr Reddy's Laboratories

Stocks

More on Dr Reddy's Laboratories

Please read our terms of use before posting comments
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
comments powered by Disqus